# Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)

> **NCT00604812** · PHASE1 · COMPLETED · sponsor: **Organon and Co** · enrollment: 31 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** rizatriptan benzoate (5 mg)
- **DRUG:** rizatriptan benzoate (10 mg)
- **DRUG:** Rizatriptan 5 mg Placebo
- **DRUG:** Rizatriptan 10 mg Placebo

## Key facts

- **NCT ID:** NCT00604812
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-17
- **Primary completion:** 2010-09-17
- **Final completion:** 2010-09-17
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00604812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00604812, "Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00604812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*